Abstract
Highlights
This report:
- Determines the status of current and next generation DNA sequencing
technologies and products, and assesses their worldwide growth potential over
a five-year period from 2008 to 2013
- Characterizes and quantifies the DNA sequencing market potential for
research tools, drug discovery and development, diagnostics, personal
genetics, forensics, agriculture, bioenergy, biosecurity, and sequencing
services
- Presents a comprehensive discussion of state-of-the-art DNA sequencing
technologies, and the current and future commercial potential for the key
market segments
- Provides forecasts from 2008 through 2013 for each of the important
products and technologies for the R&D tools, drug discovery, and development
segments
- Provides forecasts from 2008 through 2013 for the novel DNA
sequencing-based diagnostics expected to come onto the market for the
diagnostics segment
Scope of Report
The study scope includes DNA sequencing technologies likely to be
commercialized within the next five years. Sanger and next generation
(non-Sanger sequencing) technologies are included. Each technology is analyzed
to determine its market status, impact on future market segments, and
forecasted growth from 2008 through 2013. Advantages and limitations of each
technology together with market driving forces are discussed.
BCC examines the sequencing industry structure, strategic industry alliances
and acquisitions, and sequencing patents. The strategies of the main Sanger
and next generation sequencing companies are discussed. The markets for
sequencing applications, including de novo whole genome sequencing,
re-sequencing, ChipSeq, MethylSeq and RNASeq, are analyzed.
Methodology
BCC surveyed key users and producers in each of the market applications that
will be commercially important during the next five years: research, drug
discovery and development, forensics and human ID, bacterial genomics,
agricultural genomics, clinical diagnostics and personal genomics. Based on
our industry discussions and market analysis, we project the future
applications of sequencing platforms and forecast sales revenues for 2008
through 2013.
The sequencing market is analyzed by technology, product type, application,
customer, analysis type, geography and genome type, with forecasts of market
demand from 2008 through 2013. We analyze which applications and analyses will
be important to the future of DNA sequencing, and the customer groups that
will be consumers of the technologies. We also analyze the impact of other
genetic analysis technologies like microarrays on the growth of sequencing.
|